Academic Journal
Q1JAMA Psychiatry
About JAMA Psychiatry
JAMA Psychiatry is a scholarly journal published by American Medical Association. SCImago 2025 places it in Q1 with an SJR of 5.335 and an H-index of 429.
Its listed coverage is 2013-2026 and its research categories include Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1). The 2025 dataset reports 194 documents and 6932 citations across the latest three-year reporting window.
JAMA Psychiatry is one of the most prestigious and influential peer-reviewed journals in the field of psychiatry, mental health, and behavioral sciences. Published by the American Medical Association (AMA), the journal is part of the renowned Journal of the American Medical Association (JAMA) Network. It is dedicated to publishing innovative research, comprehensive reviews, and thought-provoking editorials that advance the understanding, prevention, diagnosis, and treatment of psychiatric disorders.
Leading Journal in Psychiatric Research
Ranked among the top psychiatry journals globally, JAMA Psychiatry consistently publishes high-impact research. It has a strong reputation for scientific rigor, clinical relevance, and editorial excellence. The journal covers a wide range of topics including depression, anxiety, schizophrenia, bipolar disorder, substance use disorders, neurodevelopmental conditions, and emerging areas like digital mental health and precision psychiatry.
As of recent citation metrics, JAMA Psychiatry holds one of the highest Impact Factors in the field, making it a go-to source for mental health professionals, clinicians, researchers, and policymakers.
Mission and Scope
The core mission of JAMA Psychiatry is to improve the lives of individuals with mental health conditions through the dissemination of cutting-edge research and evidence-based practices. The journal welcomes original research articles, clinical trials, meta-analyses, systematic reviews, commentaries, and viewpoints.
Key areas of interest include:
-
Neuroscience and psychopharmacology
-
Clinical psychiatry and psychotherapy
-
Mental health epidemiology
-
Social and cultural aspects of psychiatry
-
Digital interventions and AI in mental health
-
Mental health policy and systems research
By encouraging interdisciplinary collaboration, JAMA Psychiatry fosters a deeper understanding of how biological, psychological, and social factors interact in mental health and illness.
Audience and Contributors
JAMA Psychiatry serves a broad and diverse readership. This includes psychiatrists, psychologists, neuroscientists, social workers, and public health professionals. The journal is also widely used in academic and medical training programs and is frequently cited in clinical guidelines and public health strategies.
Contributors to the journal include leading experts from around the world, as well as early-career researchers and clinicians. Each submission undergoes a rigorous peer-review process to ensure the highest standards of scientific integrity and relevance.
Accessibility and Digital Presence
As part of the JAMA Network, JAMA Psychiatry offers open access options and online-first publication, ensuring timely dissemination of new findings. The journal also engages readers through podcasts, visual abstracts, social media updates, and email alerts, helping to bridge the gap between research and practice.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
JAMA Psychiatry is one of the most prestigious peer-reviewed medical journals in the field of psychiatry. Published by the American Medical Association (AMA), this journal serves as a leading platform for high-impact research, reviews, and scholarly discussions that significantly advance the understanding of mental health, psychiatric disorders, and behavioral sciences.
What Is JAMA Psychiatry?
Formerly known as Archives of General Psychiatry, JAMA Psychiatry is part of the renowned JAMA Network. It has consistently ranked among the top journals in psychiatry and mental health, with a high impact factor that reflects the relevance and scientific quality of its published work. JAMA Psychiatry targets a wide audience, including clinicians, researchers, educators, and policy makers.
Core Scope and Focus Areas
The scope of JAMA Psychiatry is broad, yet highly focused on publishing original, evidence-based research that drives the field forward. The journal emphasizes rigorous methodology, clinical relevance, and innovation. Key areas of interest include:
-
Neurobiology and Genetics of Mental Disorders: Research exploring the biological underpinnings of psychiatric conditions such as depression, schizophrenia, bipolar disorder, and anxiety.
-
Psychiatric Epidemiology: Large-scale studies analyzing the prevalence, risk factors, and outcomes of mental health disorders in populations.
-
Clinical Trials and Treatment: Articles reporting on new pharmacological and psychotherapeutic treatments, including randomized controlled trials (RCTs).
-
Health Services Research: Insights into how mental health care is delivered, its effectiveness, accessibility, and equity.
-
Global Mental Health: Studies that address psychiatric issues from an international and cross-cultural perspective.
-
Ethics and Policy: Analysis of ethical concerns and public policies affecting psychiatric care and research.
Importance of JAMA Psychiatry in Mental Health Research
JAMA Psychiatry plays a pivotal role in shaping modern psychiatric practice. It frequently publishes studies that influence clinical guidelines and mental health policy worldwide. Due to its rigorous peer-review process, the journal ensures that each article maintains the highest standards of scientific integrity and ethical responsibility.
With an emphasis on transparency and reproducibility, the journal is a trusted source for cutting-edge psychiatric research. Its commitment to open science, data sharing, and reporting guidelines further increases its impact on the mental health research community.
Why Publish or Read JAMA Psychiatry?
For authors, publishing in JAMA Psychiatry means visibility, credibility, and influence. Its broad readership includes the world’s leading mental health professionals. For readers, it offers timely updates on innovative treatments, breakthrough discoveries, and critical analysis of psychiatric practices and outcomes.
Whether you're a clinician seeking evidence-based approaches to mental illness or a researcher aiming to stay updated on the latest psychiatric advancements, JAMA Psychiatry is an essential resource.
Recent Research Articles
Latest publications matched automatically by ISSN.
GLP-1 Receptor Agonist Prescriptions Among People With and Without Serious Mental Illness
Emma E. McGinty, Pradhyumna Wagle, Gail L. Daumit
2026-09-02 · DOI: 10.1001/jamapsychiatry.2026.2667Serial Ketamine Infusions for Treatment-Resistant Bipolar Depression
Diana K. Orsini, Sara Di Luch, George Tomlinson, Gabrielle F. M. Lovell et al.
2026-09-02 · DOI: 10.1001/jamapsychiatry.2026.2658JAMA Psychiatry
2026-09-01 · DOI: 10.1001/jamapsychiatry.2025.2834Neurometabolites and Antipsychotic Response in Psychosis
Bridget King, Kirsten Borup Bojesen, Charlotte Crisp, Andrea de Bartolomeis et al.
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1674Psychedelics Trials and Outcomes—A Closer Look—Reply
Balázs Szigeti, Zachary J. Williams
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1951Psychedelics Trials and Outcomes—A Closer Look
Laetitia Vanderijst, Amandine Luquiens
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1945LLMs as Clinical Instruments—Toward Verifiable Reasoning
Martin P. Paulus, John Torous
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.2211Errors in Results
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.2129The Reinforcement Effect of Social Media Likes in Depression
Dan-Mircea Mirea, Stephenie Chen, Jialing Ding, Kepler Palacio-Soto et al.
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1430Gastrointestinal Interoception and Relapse in Anorexia Nervosa
Charles Verdonk, Keller Mink, Emily Choquette, Scott E. Moseman et al.
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1301The 25-Year Evolution of Lithium as a Disease-Modifying Agent in Dementia
Gregory J. Moore, Niranjan Bose, Ioline D. Henter, Husseini K. Manji et al.
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1296War and Suicide in the US Military
Mark A. Reger, Tim Hoyt
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1762Changes in Genetic Contributions to ASD and ADHD by Year of Diagnosis
Sonja LaBianca, Mette Lise Lousdal, Morten Dybdahl Krebs, Ole Sahlholdt Hansen et al.
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1450Mapping 2-Year Psychiatric and Neurologic Risks After Infections Across Body Systems and Age Groups
Maxime Taquet, Patrick Oliver, Ahmad Mezher, Campbell Robertson et al.
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1904Psychedelics Trials and Outcomes— A Closer Look
Sandeep M. Nayak, Brandon Weiss, David B. Yaden
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1942Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics
Nicolette Stogios, Sri Mahavir Agarwal, Kateryna Maksyutynska, Halima Faisal et al.
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1814Do Likes Reinforce Depression?
Quentin J. M. Huys, Amy Orben
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1373From Schedule I to the Clinic—Insights Into Psychedelic Drug Development From GHB
Brian S. Barnett, Franklin King
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1901The Clinical Threshold for Treatment in Psychiatry
Giovanni A. Fava, Jenny Guidi
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.1759Error in Table
2026-09-01 · DOI: 10.1001/jamapsychiatry.2026.2240Reviews
Community Reviews
Version History
April 19, 2025 at 5:17 pm
April 19, 2025